Orogen Royalties Inc. (TSXV:OGN)
Canada flag Canada · Delayed Price · Currency is CAD
3.430
+0.140 (4.26%)
At close: Feb 3, 2026

Orogen Royalties Income Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
8.877.935.983.780.640
Revenue Growth (YoY)
20.95%32.54%58.11%492.06%103628.90%-99.68%
Cost of Revenue
----0.150.37
Gross Profit
8.877.935.983.780.49-0.37
Selling, General & Admin
3.53.243.12.72.712.44
Other Operating Expenses
--0.07--1.44-0.01
Operating Expenses
5.125.054.683.893.124.88
Operating Income
3.752.881.31-0.11-2.63-5.25
Interest & Investment Income
0.590.580.260.090.10.09
Currency Exchange Gain (Loss)
-0.530.63-0.240.16-0.06-0.01
Other Non Operating Income (Expenses)
0.04-0.2-0.07-0.08-0.1-0.03
EBT Excluding Unusual Items
3.853.891.250.07-2.69-5.2
Gain (Loss) on Sale of Investments
2.460.370.670.64-0.010.17
Pretax Income
6.34.261.920.71-2.7-5.02
Income Tax Expense
2.161.67-1.12-0.130.13-
Net Income
4.142.593.040.84-2.83-5.02
Net Income to Common
4.142.593.040.84-2.83-5.02
Net Income Growth
152.31%-14.86%262.35%---
Shares Outstanding (Basic)
445047454430
Shares Outstanding (Diluted)
445251525230
Shares Change (YoY)
-15.89%1.57%-1.03%0.05%76.12%39.46%
EPS (Basic)
0.100.050.060.02-0.06-0.17
EPS (Diluted)
0.080.040.040.02-0.08-0.17
EPS Growth
5791.84%-147.49%---
Free Cash Flow
2.083.05-0.50.78-3.56-3.87
Free Cash Flow Per Share
0.050.06-0.010.01-0.07-0.13
Gross Margin
100.00%100.00%100.00%100.00%76.75%-
Operating Margin
42.25%36.36%21.83%-2.84%-411.29%-852233.44%
Profit Margin
46.73%32.70%50.90%22.21%-443.13%-815580.03%
Free Cash Flow Margin
23.50%38.49%-8.34%20.60%-557.66%-627731.33%
EBITDA
3.853.041.340.35-1.19-3.68
EBITDA Margin
43.44%38.33%22.34%9.17%-185.51%-
D&A For EBITDA
0.110.160.030.451.441.57
EBIT
3.752.881.31-0.11-2.63-5.25
EBIT Margin
42.25%36.36%21.83%-2.84%--
Effective Tax Rate
34.24%39.13%----
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.